
|Videos|August 11, 2022
Case Presentation: An 81-Year-Old Male with AML
Author(s)Hetty E. Carraway, MD, Eytan Stein, MD
Eytan Stein, MD, presents the case of an 81-year-old patient with AML who is unfit for intensive induction therapy for discussion.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
2
Trial Data Show Efficacy, Tolerability of Nivolumab Plus Visogromab in MIBC
3
FDA Grants Orphan Drug Status to Novel CD33-Directed Immunotherapy for AML
4
Domvanalimab Combo Shows Enriched First-Line Efficacy in Advanced GI Cancers
5









































